Chloroquine neuromyopathy

Clinical Neuropathology

Volumn 15, Issue 5, 1996, Pages 256-258

  Nucci, A ^a   Queiroz, L S ^a   Samara, A M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Amphiphilic drug myopathy; Chloroquine toxicity; Lysosomal storage myopathy; Neuromyopathy

Indexed keywords

CHLOROQUINE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DRUG TOXICITY; ENZYME HISTOCHEMISTRY; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LYSOSOME STORAGE DISEASE; MUSCLE BIOPSY; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; ULTRASTRUCTURE;

ADENOSINE TRIPHOSPHATASES; ARTHRITIS, RHEUMATOID; CHLOROQUINE; FEMALE; HUMANS; MIDDLE AGED; MOTOR NEURON DISEASE; MUSCLE FIBERS;

EID: 0029825701     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Avina-Zubieta JA, Johnson ES, Suarez-Almazor ME, Russell AS 1995 Incidence of myopathy in patients treated with antimalarials. A report of three cases and a review of the literature. Br J Rheumatol 34: 166-170
2. Bernstein HN 1991 Ocular safety of hydroxychloroquine. Ann Ophthalmol 23: 292-296
3. Cubero IG, Reguero JJR, Ortega JMR 1993 Restrictive cardiomyopathy caused by chloroquine. Br Heart J 69: 451-452
4. De Bleecker J, De Reuck J, Quatacker J, Meire F 1991 Persisting chloroquine-induced myasthenia? Acta Clin Belg 46. 401-406
5. Drenckhahn D, Lüllmann-Rauch R 1979 Experimental myopathy induced by amphiphilic cationic compounds including several psychotropic drugs. Neuroscience 4: 549-562
6. Eadie MJ, Ferrier TM 1966 Chloroquine myopathy. J Neurol Neurosurg Psychiatry 29: 331-337
7. Estes ML, Ewing-Wilson D, Chou SM, Mitsumoto H, Hanson M, Shirey E, Ratliff NB 1987 Chloroquine neuromyotoxicity. Clinical and pathologic perspective. Am J Med 82: 447-455
8. Frisk-Holmberg M, Bergkvist Y, Domeij-Nyberg B, Hellström L, Jansson F 1979 Chloroquine serum concentration and side effects: evidence for dose-dependent kinetics. Clin Pharmacol Ther 25: 345-350
9. Kumamoto T, Araki S, Watanabe S, Ikebe N, Fukuhara N 1989 Experimental chloroquine myopathy: morphological and biochemical studies. Eur Neurol 29: 202-207
10. Kumamoto T, Ueyama H, Watanabe S, Murakami T, Araki S 1993 Effect of denervation on overdevelopment of chloroquine-induced autophagic vacuoles in skeletal muscles. Muscle Nerve 16: 819-826
11. Mackenzie AH 1983 Pharmacologic actions of 4-aminoquinoleine compounds. Am J Med 75 (Suppl 1A): 5-10
12. Mastagha FL, Papadimitriou JM, Dawkins RL, Beveridge B 1977 Vacuolar myopathy associated with chloroquine, lupus erythematosus and thymoma. J. Neurol Sci 34: 315-328
13. MCAllister Jr HA, Ferrans VJ, Hall RJ, Strickman NE, Bossart MI 1987 Chloroquine-induced cardiomyopathy. Arch Pathol Lab Med 111. 953-956
14. Rion B, Barriot P, Rimailho A, Baud FJ 1988 Treatment of severe chloroquine poisoning. N Engl J Med 318: 1-6
15. Sghirlanzoni A, Mantegazza R, Mora M, Pareyson D, Cornelio F 1988 Chloroquine myopathy and myasthenia-like syndrome. Muscle Nerve 11: 114-119
16. Stiff G, Robinson D, Cugnoni HL, Touquer R, Dalton AM 1991 Massive chloroquine overdose - a survivor. Postgrad Med J 67: 678-679
17. Tegnér R, Tomé FMS, Godeau P, Lhermutte F, Fardeau M 1988 Morphological study of peripheral nerve changes induced by chloroquine treatment. Acta Neuropathol (Berl) 75 253-260
18. Whisnant JP, Espinosa RE, Kierland RR, Lambert EH 1963 Chloroquine neuromyopathy. Mayo Clin Proc 38: 501-513